-
-
-
-
-
-
-
Seagen Second Quarter 2023 Financial Results Demonstrate Exceptional Commercial Performance Driving Record Product Sales with Strong Growth and Momentum
-
-
-
-
-
-
-
Pfizer (PFE) Acquires Seagen (SGEN) for $43B or $229/sh
-
-
-
-
-
-
-
Seagen (SGEN) extends gains on two analyst upgrades after earnings
-
-
-
-
-
-
-
Seagen to Host Conference Call and Webcast Discussion of Third Quarter 2022 Financial Results on October 27, 2022
-
-
-
-
-
-
-
Merck's (MRK) Seagen (SGEN) Deal Delayed, Talks on Track - WSJ (earlier)
-
-
-
-
-
-
-
Seagen to Host Conference Call and Webcast Discussion of First Quarter 2022 Financial Results on April 28, 2022
-
-
-
-
-
-
-
Seagen (SGEN) Stock Plunges on Weak Outlook and Q4 Miss, Analysts Lower Price Targets
-
968,257 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All